Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

4
29
0
7

Year Published

2019
2019
2020
2020

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 37 publications
(40 citation statements)
references
References 30 publications
(40 reference statements)
4
29
0
7
Order By: Relevance
“…Our study suggests that women with breast cancer who received SC with both A and T chemotherapy were significantly more likely (57% versus 0%) to have successful HP than those who did not receive SC. This is consistent with results from recent studies which show success of scalp cooling in ∼30–80% patients [ [11] , [12] , [13] , [14] , [15] , [16] , [17] , [18] , [19] ]. Also, though SC has mostly been studied in females undergoing treatment for breast cancer, many of the studies are in patients with early breast cancer [ 13 , 14 , 16 , [26] , [27] , [28] , [29] ].…”
Section: Discussionsupporting
confidence: 93%
See 1 more Smart Citation
“…Our study suggests that women with breast cancer who received SC with both A and T chemotherapy were significantly more likely (57% versus 0%) to have successful HP than those who did not receive SC. This is consistent with results from recent studies which show success of scalp cooling in ∼30–80% patients [ [11] , [12] , [13] , [14] , [15] , [16] , [17] , [18] , [19] ]. Also, though SC has mostly been studied in females undergoing treatment for breast cancer, many of the studies are in patients with early breast cancer [ 13 , 14 , 16 , [26] , [27] , [28] , [29] ].…”
Section: Discussionsupporting
confidence: 93%
“…This could be attributed to multiple cancer types being enrolled in trials, varied CT regimens, intrinsic patient/hair characteristics, technical reasons like optimal cap fit, and use of non-validated outcome measures (use of wigs, subjective hair loss assessment) [ 3 , 6 , 11 ]. A meta-analysis as well as other randomized control trials (RCTs) showed positive results with SC with acceptable tolerance [ 9 , [12] , [13] , [14] ]. Various other non-randomized studies have also reported beneficial outcomes with SC [ [15] , [16] , [17] , [18] , [19] ].…”
Section: Introductionmentioning
confidence: 99%
“…Chemotherapy-induced alopecia is generally reversible, and hair regrowth is predicted to begin 3–6 months after chemotherapy (21). Although most previous studies of scalp cooling have observed the degree of hair loss during the chemotherapy or 4 weeks after completion of chemotherapy (Table 5) (6, 7, 1419), Smetanay et al reported that 6 months after chemotherapy, most patients experienced ≥75% hair recovery regardless of whether or not they used a scalp-cooling device (15). To the best of our knowledge, this is the first study to compare the hair recovery process in detail by independent assessors using a grading scale between patients who did and did not use scalp-cooling treatment.…”
Section: Discussionmentioning
confidence: 99%
“…There might be risk factors of CIA, for example it might occur when a patient has an inflammatory lesion such as seborrheic eczema or a fragile vascular condition. Currently, only the scalp‐cooling device is effective to some extent as CIA prevention and has been clinically applied 20,21 . There are two known mechanisms of CIA prevention by the scalp‐cooling method: to inhibit the anticancer drug itself from reaching the peripheral blood vessels of the scalp by contracting the blood vessel, and to attenuate the action of the anticancer drug by deviating from the optimal temperature of the action of the anticancer drug.…”
Section: Discussionmentioning
confidence: 99%